What is Vaxcyte, Inc.'s net investment in lease?

Vaxcyte, Inc. (PCVX) reported net investment in lease of $113.1M in Q1 2026.

How has Vaxcyte, Inc.'s net investment in lease changed year-over-year?

Vaxcyte, Inc.'s net investment in lease increased by 28.9% year-over-year, from $87.76M to $113.1M.

What is the long-term trend for Vaxcyte, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Vaxcyte, Inc.'s net investment in lease has grown at a 164.3% compound annual growth rate (CAGR), from $900K to $116.01M.

Vaxcyte, Inc. PCVX Net Investment in Lease

Net Investment in Lease at other companies

ModernaMRNA

——

Krystal Biotech, Inc.KRYS

——

ImmunityBio, Inc.IBRX

——

Vertex PharmaceuticalsVRTX

——

Other financials

Income statement

See full

Operating income-$345.9M-91.3%

Net income-$320.6M-128%

EPS (diluted)-$2.30-121%

Balance sheet

See full

Cash & equivalents$262.3M-24.7%

Total debt$116.3M+33.5%

Total equity$3.0B-6.4%

Total assets$3.3B-0.9%

Cash flow

See full

Operating cash flow-$280.6M-68.8%

CapEx$2.1M-61.2%

Free cash flow-$282.7M-64.7%

Valuation

See full

Market cap$7.43B+72.0%

Enterprise value$7.28B+78.6%

Returns & leverage

See full

Return on equity-30.6%+37.9pp

Debt / equity0×0.0×

Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vaxcyte, Inc.'s net investment in lease?: Vaxcyte, Inc. (PCVX) reported net investment in lease of $113.1M in Q1 2026.
How has Vaxcyte, Inc.'s net investment in lease changed year-over-year?: Vaxcyte, Inc.'s net investment in lease increased by 28.9% year-over-year, from $87.76M to $113.1M.
What is the long-term trend for Vaxcyte, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Vaxcyte, Inc.'s net investment in lease has grown at a 164.3% compound annual growth rate (CAGR), from $900K to $116.01M.